|
⚲
|
| Keyboard |
| Third Rock Ventures V LP
✚
|
|
|---|---|
| CIK # | 0001778071 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001778071] | |
| 4 | [0001778071] | |
| D | [0001778071] | |
| SC 13G | [0001778071] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Third Rock Ventures V LP | Rapport Therapeutics Inc | [2025-02-13] |
| Third Rock Ventures V LP | Septerna Inc | [2025-02-13] |
| Third Rock Ventures V LP | Cargo Therapeutics Inc | [2024-02-14] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Maze Therapeutics Inc MAZE
Common Stock
|
2025-11-04 | Other | 1,600,000 | ||
|
Septerna Inc SEPN
Common Stock
|
2025-02-24 | Buy | 18,861 | $6.00 | 113,166 |
|
Septerna Inc SEPN
Common Stock
|
2025-02-21 | Buy | 427,668 | $5.94 | 2,540,348 |
|
Septerna Inc SEPN
Common Stock
|
2025-02-20 | Buy | 612,674 | $5.92 | 3,627,030 |
|
Maze Therapeutics Inc MAZE
Common Stock
|
2025-02-03 | Conversion | 950,800 | $0.00 | |
|
Maze Therapeutics Inc MAZE
Common Stock
|
2025-02-03 | Conversion | 5,762,788 | $0.00 | |
|
Maze Therapeutics Inc MAZE
Series D-1 Preferred Stock · derivative
|
2025-02-03 | Conversion | 9,725,709 | $0.00 | |
|
Maze Therapeutics Inc MAZE
Series A Preferred Stock · derivative
|
2025-02-03 | Conversion | 9,166,666 | $0.00 | |
|
Maze Therapeutics Inc MAZE
Series A Preferred Stock · derivative
|
2025-02-03 | Conversion | 45,833,334 | $0.00 | |
|
Septerna Inc SEPN
Common Stock
|
2024-10-28 | Conversion | 2,872,956 | $0.00 | |
|
Septerna Inc SEPN
Common Stock
|
2024-10-28 | Conversion | 4,790,773 | $0.00 | |
|
Septerna Inc SEPN
Common Stock
|
2024-10-28 | Buy | 370,500 | $18.00 | 6,669,000 |
|
Septerna Inc SEPN
Common Stock
|
2024-10-28 | Buy | 279,500 | $18.00 | 5,031,000 |
|
Septerna Inc SEPN
Series A Preferred Stock · derivative
|
2024-10-28 | Conversion | 41,250,000 | $0.00 | |
|
Septerna Inc SEPN
Series B Preferred Stock · derivative
|
2024-10-28 | Conversion | 24,737,017 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2024-06-10 | Conversion | 6,551,449 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Series A Preferred Stock · derivative
|
2024-06-10 | Conversion | 56,091,177 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Series A Preferred Stock · derivative
|
2024-06-10 | Conversion | 8,000,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Series B Preferred Stock · derivative
|
2024-06-10 | Conversion | 298,103 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2024-06-10 | Conversion | 969,218 | $0.00 | |
| showing 20 of 25 most recent transactions | |||||